GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $21.75 $29.93 Friday, 19th Apr 2024 ARWR stock ended at $22.33. This is 1.24% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.64% from a day low at $21.75 to a day high of $22.76.
90 days $21.75 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
2021-03-19 $67.86 $68.85 $65.59 $67.40 1 992 683
2021-03-18 $71.01 $71.75 $67.69 $67.84 681 231
2021-03-17 $70.47 $73.38 $69.50 $72.57 460 241
2021-03-16 $73.40 $74.46 $70.44 $71.97 510 295
2021-03-15 $72.90 $73.21 $70.48 $71.85 795 955
2021-03-12 $72.11 $72.84 $70.32 $72.74 513 180
2021-03-11 $71.61 $73.64 $70.87 $73.18 655 460
2021-03-10 $71.44 $73.48 $69.20 $69.63 723 600
2021-03-09 $65.82 $71.50 $65.81 $69.87 912 198
2021-03-08 $69.10 $71.08 $64.30 $64.58 1 187 414
2021-03-05 $70.00 $70.50 $62.99 $69.00 1 610 045
2021-03-04 $77.08 $77.08 $68.07 $69.56 1 763 646
2021-03-03 $80.61 $80.97 $75.17 $75.48 889 753
2021-03-02 $83.25 $83.89 $80.32 $80.63 721 133
2021-03-01 $81.14 $84.45 $81.06 $83.78 566 453
2021-02-26 $83.01 $84.49 $78.91 $79.66 1 053 117
2021-02-25 $84.16 $86.44 $81.10 $82.20 614 724
2021-02-24 $82.48 $85.48 $80.42 $85.03 687 269
2021-02-23 $82.82 $83.00 $78.01 $81.75 1 311 872
2021-02-22 $88.29 $89.37 $84.71 $85.00 765 678
2021-02-19 $87.30 $90.40 $86.06 $89.51 679 126
2021-02-18 $84.69 $86.97 $83.00 $86.46 749 077
2021-02-17 $86.71 $87.82 $84.59 $86.70 850 871
2021-02-16 $89.03 $89.36 $85.37 $87.40 565 831
2021-02-12 $88.46 $89.91 $86.70 $88.20 489 166
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT